GlassScriptPhysician profile
Vivek Bhupathi
NPI 1780172775
$29,278.29
in general payments reported to CMS, 2019-2025
26 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.14 · 2022: $2,613 · 2023: $4,755 · 2024: $2,679 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $10K · Grant: $1,063 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,418.87 |
| Food and Beverage | $10,020.05 |
| Grant | $1,063.30 |
| Education | $148.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,418.56 | 2022-2025 | Ensite Precision, Ensite, Amplatzer Amulet |
| Boston Scientific Corporation | $7,404.97 | 2023-2025 | Farapulse, Ingevity+, Versacross Connect Laac Access Solution |
| Biotronik INC. | $6,084.44 | 2025 | |
| Medtronic, INC. | $3,640.84 | 2022-2025 | Micra, Symplicity G3, Aurora Ev-Icd Mri Surescan |
| Abiomed | $999.95 | 2023-2025 | Impella |
| Shockwave Medical, INC | $690.38 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $372.90 | 2021-2024 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $245.68 | 2023-2024 | Lifevest |
| Cardiva Medical, INC. | $228.65 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Penumbra, INC. | $212.58 | 2022-2024 | Indigo System, Penumbra System |
| Impulse Dynamics (USA) INC. | $157.81 | 2023 | Optimizer |
| Edwards Lifesciences Corporation | $153.84 | 2023 | |
| Biosense Webster, INC. | $141.52 | 2023 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $111.85 | 2023 | Farxiga |
| Cook Medical LLC | $57.69 | 2024 | Advance |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $56.49 | 2022 | |
| Janssen Pharmaceuticals, INC | $54.32 | 2024 | Xarelto |
| Amgen INC. | $50.00 | 2024 | Repatha |
| Novo Nordisk INC | $39.91 | 2022 | |
| Merck Sharp & Dohme LLC | $34.27 | 2023 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $26.76 | 2024 | Arcalyst |
| Heartflow, INC. | $25.54 | 2023 | Ffrct |
| Scpharmaceuticals INC. | $19.91 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $19.26 | 2023 | Inpefa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.23 | 2022 | |
| Pfizer INC. | $13.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Bhupathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.